Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE4236.955.65 (+0.13 %)
PREV CLOSE ( ) 4231.30
OPEN PRICE ( ) 4215.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1245
TODAY'S LOW / HIGH ( )4197.25 4275.00
52 WK LOW / HIGH ( )1888 4970
NSE4238.609.1 (+0.22 %)
PREV CLOSE( ) 4229.50
OPEN PRICE ( ) 4210.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12432
TODAY'S LOW / HIGH( ) 4205.15 4278.85
52 WK LOW / HIGH ( )1885 4970
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

16Oct AstraZeneca Pharma planning to launch
AstraZeneca Pharma is planning to launch Acalabrutinib 100mg capsules (C..
16Oct AstraZeneca Pharma jumps on planning t
Astrazeneca Pharma India is currently trading at Rs. 4297.00, up by 30.3..
08Sep Astrazeneca Pharma India informs about
With reference to letter dated August 10, 2020, wherein the Company had..
04Aug Astrazeneca Pharma India informs about
Astrazeneca Pharma India has informed that a meeting of the Board of Dir..
17Jul Astrazeneca Pharma India informs about
Astrazeneca Pharma India has informed that pursuant to Regulation 30 rea..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit186.34722.1
Gross Profit 263.84 1139.6
Operating Profit 312.21336.81
Net Sales 1935.778318.09

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Valiant Organics (BSE)
peergroup  3502.50 (6.71%)
M.Cap ( in Cr)4755.25
Hester Biosciences (BSE)
peergroup  1843.00 (3.92%)
M.Cap ( in Cr)1567.82
Pfizer (BSE)
peergroup  5112.85 (1.00%)
M.Cap ( in Cr)23390.13
Torrent Pharma (BSE)
peergroup  2734.35 (0.74%)
M.Cap ( in Cr)46267.59
Ipca Laboratories (BSE)
peergroup  2173.00 (0.90%)
M.Cap ( in Cr)27564.96

Shareholding Pattern

PROMOTERS 75%
NON-INSTITUTION 20.69%
MUTUAL FUNDS/UTI 2.22%
FI/BANKS/INSURANCE 0.02%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 4236.95. Its current market capitalisation stands at Rs 10592.38 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8318.1 Cr and Total Income of Rs.8448 Cr. The company's management includes Ankush Nandra, Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Kimsuka Narsimhan, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are ACC Ltd. It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)